Drugs / Fluzone I®ntradermal vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02258334 | Oct → Nov 2014 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone Intradermal vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258334 ↗ |
| Modality | Vaccine | “Fluzone® Intradermal vaccines” NCT02258334 ↗ |